BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Jun 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-06-18

Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-18	Common Stock	S	3500	$14.00	Disposed	149644	Direct
2015-06-18	Common Stock	M	3100	$3.78	Acquired	152744	Direct
2015-06-18	Common Stock	M	3100	$3.78	Acquired	155844	Direct
2015-06-18	Common Stock	S	3100	$14.25	Disposed	152744	Direct
2015-06-18	Common Stock	S	3100	$13.50	Disposed	149644	Direct
2015-06-19	Common Stock	S	3500	$15.00	Disposed	146144	Direct
2015-06-19	Common Stock	M	3175	$3.78	Acquired	149319	Direct
2015-06-19	Common Stock	S	3175	$15.00	Disposed	146144	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-18	Stock Option (Right to Buy)	$3.78	M	3100	Disposed	2021-07-01	Common Stock (3100)	Direct
2015-06-18	Stock Option (Right to Buy)	$3.78	M	3100	Disposed	2021-07-01	Common Stock (3100)	Direct
2015-06-19	Stock Option (Right to Buy)	$3.78	M	3175	Disposed	2021-07-01	Common Stock (3175)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2014.